Jeff Liter

Jeff Liter

Company: Luminary Therapeutics

Job title: Chief Executive Officer


Leveraging Gamma Delta Cells to Enhance Accessibility of Allogeneic Therapies 3:00 pm

Exploring the Allogeneic Gamma 2.0+ Platform as a rapidly expanding solution to make off-the-shelf therapies more cost effective Enhancing T-cell expansion to minimize dosing delays, effectively catering to patients with hard-to-treat diseases Strategizing ways to enhance cost-effectiveness in the production of allogeneic cell therapies for broader patient accessibilityRead more

day: Pre-Clinical Track Day Two PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.